Protagonist Therapeutics, Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 62,457,444
- Total 13F shares
- 70,684,460
- Share change
- -284,334
- Total reported value
- $4,695,410,423
- Put/Call ratio
- 30%
- Price per share
- $66.43
- Number of holders
- 274
- Value change
- +$4,458,380
- Number of buys
- 122
- Number of sells
- 148
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
14%
|
8,575,669
|
$569,681,692 | -$33,813,734 | 30 Sep 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.9%
|
6,172,006
|
$341,126,772 | — | 30 Jun 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
9.2%
|
5,756,277
|
$318,149,430 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
7%
|
4,358,595
|
$240,899,545 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
2.8%
from 13D/G
|
3,245,899
|
$179,400,838 | — | 30 Jun 2025 | |
| BVF INC/IL |
13F
|
Company |
5.1%
|
3,211,041
|
$177,474,236 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
5.2%
from 13D/G
|
3,207,543
|
$177,280,902 | — | 30 Jun 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
4.1%
|
2,560,916
|
$170,121,650 | -$43,187,804 | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
4%
|
2,501,251
|
$138,244,142 | — | 30 Jun 2025 | |
| JOHNSON & JOHNSON |
13F
|
Company |
3.9%
|
2,449,183
|
$136,395,001 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,444,230
|
$79,833,120 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.7%
|
1,092,262
|
$60,369,321 | — | 30 Jun 2025 | |
| Commodore Capital LP |
13F
|
Company |
1.7%
|
1,075,000
|
$59,415,250 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.7%
|
1,074,448
|
$59,384,741 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.7%
|
1,037,738
|
$57,355,780 | — | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
1.5%
|
948,069
|
$52,399,774 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
1.5%
|
946,884
|
$52,334,279 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.5%
|
936,703
|
$51,773,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
868,963
|
$48,027,638 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
851,832
|
$47,080,755 | — | 30 Jun 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
1.3%
|
824,019
|
$45,543,530 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.3%
|
813,995
|
$44,989,586 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
777,307
|
$42,961,758 | — | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
757,710
|
$41,878,632 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.2%
|
751,977
|
$41,561,769 | — | 30 Jun 2025 | |
| Lynx1 Capital Management LP |
13F
|
Company |
1.2%
|
733,014
|
$40,513,684 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.2%
|
721,680
|
$39,887,254 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.98%
|
615,066
|
$33,994,698 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.92%
|
575,364
|
$31,800,368 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0.86%
|
538,432
|
$29,759,137 | — | 30 Jun 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
0.85%
|
530,326
|
$29,311,118 | — | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.72%
|
446,828
|
$24,702,654 | — | 30 Jun 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.71%
|
446,026
|
$24,652,000 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.71%
|
445,692
|
$24,633,397 | — | 30 Jun 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0.71%
|
445,440
|
$24,619,469 | — | 30 Jun 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.71%
|
445,000
|
$24,595,150 | — | 30 Jun 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.7%
|
440,000
|
$24,318,800 | — | 30 Jun 2025 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.65%
|
405,644
|
$22,419,944 | — | 30 Jun 2025 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
0.63%
|
395,383
|
$21,852,818 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.62%
|
388,082
|
$21,449,292 | — | 30 Jun 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.53%
|
330,134
|
$18,246,507 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.5%
|
311,986
|
$17,243,466 | — | 30 Jun 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.45%
|
280,354
|
$15,495,165 | — | 30 Jun 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.44%
|
277,316
|
$15,327,255 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.39%
|
243,373
|
$13,451,225 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.34%
|
212,112
|
$11,723,430 | — | 30 Jun 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.34%
|
211,281
|
$11,677,501 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.29%
|
180,050
|
$9,952,174 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.28%
|
173,134
|
$9,569,116 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.28%
|
173,028
|
$9,563,231 | — | 30 Jun 2025 |
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q3 2025
As of 30 Sep 2025,
Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by
274 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,684,460 shares.
The largest 10 holders included
BlackRock, Inc., FARALLON CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, VANGUARD GROUP INC, STATE STREET CORP, BVF INC/IL, JOHNSON & JOHNSON, WELLINGTON MANAGEMENT GROUP LLP, UBS Group AG, and Deep Track Capital, LP.
This page lists
274
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
273
Q3 2025 holders
274
Holder diff
1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.